Sponsored Post, Events

ARPA-H Spotlights Innovative Health Tech and MedTech at INVEST Digital Health

The Innovation Showcase at the Dallas conference included technology to objectively assess pain, as well as startups seeking to speed up diagnosis of endometriosis, improve the way we communicate and precision nutrition.

At the INVEST Digital Health conference in Dallas, the Advanced Research Projects Agency for Health (ARPA-H) offered a glimpse of the kind of technology it’s funding. The federal organization funds research across focus areas that are disease agnostic, broad by design, and intersect to foster the creativity and big thinking needed for next-generation innovation, according to the ARPA-H website.

MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia conducted a series of video interviews with a selection of companies in ARPA-H’s portfolio that took part in the Innovation Showcase. Among the ambitious technologies in the showcase, one developed a way to objectively assess pain, while other startups seek to speed up endometriosis diagnoses, improve the way we communicate and offer precision nutrition to cancer patients.

AlgometRx 

Communicating pain can be a complex task in healthcare, particularly using the pain scale, since one person’s 3 could be another person’s 7. Additionally, pain reporting can be unreliable, lack sensitivity and clinical specificity. In an interview, AlgometRx COO Kevin Jackson explained to Plescia how its Nociometer is able to provide an objective assessment of pain.

Insilicom

Biomedical AI and bioinformatics startup Insilicom focuses on the niche area of precision nutrition. In an interview with Parmar, Insilicom Founder and CEO Jinfeng Zhang noted that dietary recommendations currently provided to cancer patients are often generic and fail to account for a patient’s specific genomic profile, biology, or personal preferences. 

Nura Health

Endometriosis is a condition that causes pelvic pain which can also undermine mental health with anxiety, depression and sexual dysfunction. It affects one in 10 women in the U.S. Nura Health CEO Varun Kapur, MD, noted in an interview with Plescia how it is cutting the time it takes to reach a diagnosis. He also described how the company makes use of mobile phlebotomists to reach patients where they are. 

VoiceLove

Mary Butler-Everson, VoiceLove Chief Growth Officer, and Stas Samarin, VoiceLove SVP of Product, explained how the early stage clinical company’s interventional technology seeks to support those with limited communication abilities, such as people with dementia or autism. The company’s technology harnesses AI to analyze behavioral patterns and vocalizations to help caregivers, therapists and loved ones understand what they need.

Photo: Issarawat Tattong, Getty Images